CR8569A - Inhibidores de integrasa de vih - Google Patents
Inhibidores de integrasa de vihInfo
- Publication number
- CR8569A CR8569A CR8569A CR8569A CR8569A CR 8569 A CR8569 A CR 8569A CR 8569 A CR8569 A CR 8569A CR 8569 A CR8569 A CR 8569A CR 8569 A CR8569 A CR 8569A
- Authority
- CR
- Costa Rica
- Prior art keywords
- compounds
- inhibitors
- hiv
- aids
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Compuestos de hidroxi (tetra-o-hexa-) hidronaftiridindiona de la formula I inhibidores de la integrasa de VIH e inhibidores de la replicacion de VIH en los que X1,X2,R4 y R5 se definen en la presente memoria. Los compuestos son utiles en la prevencion y tratamiento de la infeccion por VIH y en la prevencion, retraso en el inicio, y tratamiento de SIDA. Los compuestos se emplean contra la infeccion por VIH y SIDA como compuestos per se o en forma de sales farmaceuticamente aceptables. Los compuestos y sus sales pueden emplearse como ingredientes en composiciones farmaceuticas, opcionalmente combinados con otros antivirales, inmunoduladores, antibioticos o vacunas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55162504P | 2004-03-09 | 2004-03-09 | |
US63313404P | 2004-12-03 | 2004-12-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR8569A true CR8569A (es) | 2007-08-28 |
Family
ID=34962221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8569A CR8569A (es) | 2004-03-09 | 2006-08-24 | Inhibidores de integrasa de vih |
Country Status (15)
Country | Link |
---|---|
US (1) | US7598264B2 (es) |
EP (1) | EP1725556A1 (es) |
JP (1) | JP4625838B2 (es) |
KR (1) | KR20070026414A (es) |
CN (1) | CN1930160B (es) |
AU (1) | AU2005222391B2 (es) |
CA (1) | CA2558026C (es) |
CR (1) | CR8569A (es) |
EA (1) | EA200601654A1 (es) |
EC (1) | ECSP066826A (es) |
IL (1) | IL177858A0 (es) |
MA (1) | MA28519B1 (es) |
NO (1) | NO20064555L (es) |
NZ (1) | NZ549449A (es) |
WO (2) | WO2005087767A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200510425A (en) | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
CN1929737A (zh) * | 2004-03-09 | 2007-03-14 | 默克公司 | Hiv整合酶抑制剂 |
CA2557926A1 (en) * | 2004-03-09 | 2005-09-22 | Monica Donghi | Hiv integrase inhibitors |
WO2005086700A2 (en) * | 2004-03-09 | 2005-09-22 | Merck & Co., Inc. | Hiv integrase inhibitors |
BRPI0511504A (pt) | 2004-05-26 | 2008-01-22 | Eisai R&D Man Co Ltd | composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides |
EP1808432B1 (en) | 2004-10-26 | 2010-02-24 | Eisai R&D Management Co., Ltd. | Amorphous form of cinnamide compound |
CA2634499A1 (en) * | 2004-12-23 | 2006-06-29 | Virochem Pharma Inc. | Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase |
US7741315B2 (en) * | 2005-05-10 | 2010-06-22 | Merck Sharp & Dohme Corp. | HIV integrase inhibitors |
US8633298B2 (en) | 2005-09-20 | 2014-01-21 | Jitsubo Co., Ltd. | Carrier for separation, method for separation of compound, and method for synthesis of peptide using the carrier |
EP1937678B1 (en) * | 2005-10-04 | 2011-07-27 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Hiv integrase inhibitors |
AU2006306355A1 (en) * | 2005-10-27 | 2007-05-03 | Merck & Co., Inc. | HIV integrase inhibitors |
KR20080076907A (ko) * | 2005-11-18 | 2008-08-20 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신나미드 유도체의 제조 방법 |
TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
CA2645551C (en) | 2006-03-16 | 2016-06-28 | Renovis, Inc. | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
EP2084160A1 (en) * | 2006-10-18 | 2009-08-05 | Merck & Co., Inc. | Hiv integrase inhibitors |
US20080207900A1 (en) | 2007-02-28 | 2008-08-28 | Teiji Kimura | Two cyclic oxomorphorin derivatives |
US7687509B2 (en) | 2007-07-09 | 2010-03-30 | Concert Pharmaceuticals Inc. | Pyrimidinecarboxamide derivatives |
US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
CA2694401C (en) | 2007-08-31 | 2012-12-04 | Eisai R&D Management Co., Ltd. | Polycyclic compound |
US8283366B2 (en) | 2010-01-22 | 2012-10-09 | Ambrilia Biopharma, Inc. | Derivatives of pyridoxine for inhibiting HIV integrase |
US9107922B2 (en) | 2010-07-16 | 2015-08-18 | Concert Pharmaceuticals, Inc. | Pyrimidinecarboxamide derivatives |
CN103608346B (zh) * | 2011-02-02 | 2016-06-15 | 菲布罗根有限公司 | 作为缺氧诱导因子(hif)羟化酶抑制剂的萘啶衍生物 |
CN104185420B (zh) | 2011-11-30 | 2017-06-09 | 埃默里大学 | 用于治疗或预防逆转录病毒和其它病毒感染的抗病毒jak抑制剂 |
EP2877469A4 (en) * | 2012-07-25 | 2016-04-06 | Merck Sharp & Dohme | SUBSTITUTED NAPHTHYRIDINEDIONE DERIVATIVES AS INHIBITORS OF HIV INTEGRASE |
HUE036384T2 (hu) * | 2013-05-17 | 2018-07-30 | Merck Sharp & Dohme | Fúzionált triciklusos heterociklikus vegyületek mint HIV integráz inhibitorok |
WO2015048363A1 (en) * | 2013-09-27 | 2015-04-02 | Merck Sharp & Dohme Corp. | Substituted quinolizine derivatives useful as hiv integrase inhibitors |
WO2016154527A1 (en) * | 2015-03-26 | 2016-09-29 | Merck Sharp & Dohme Corp. | Phosphate-substituted quinolizine derivatives useful as hiv integrase inhibitors |
IL273553B1 (en) * | 2017-10-02 | 2024-05-01 | Novartis Ag | A method for preparing a pharmacy product |
WO2023057985A1 (en) * | 2021-10-08 | 2023-04-13 | Vrise Therapeutics, Inc. | Small molecules for treatement of cancer |
WO2023105491A1 (en) * | 2021-12-10 | 2023-06-15 | Vrise Therapeutics, Inc. | 5,6,7,8-tetrahydro-2,6-naphthyridine derivatives as cancer therapeutics |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6306891B1 (en) | 1998-06-03 | 2001-10-23 | Merck & Co., Inc. | HIV integrase inhibitors |
US6262055B1 (en) | 1998-06-03 | 2001-07-17 | Merck & Co., Inc. | HIV integrase inhibitors |
US6380249B1 (en) | 1998-06-03 | 2002-04-30 | Merck & Co., Inc. | HIV integrase inhibitors |
AU5880600A (en) | 1999-06-25 | 2001-01-31 | Merck & Co., Inc. | 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
JP2004513134A (ja) | 2000-10-12 | 2004-04-30 | メルク エンド カムパニー インコーポレーテッド | Hivインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルケトン類 |
AU1532802A (en) | 2000-10-12 | 2002-04-22 | Merck & Co Inc | Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
WO2002030930A2 (en) | 2000-10-12 | 2002-04-18 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
WO2002055079A2 (en) | 2000-10-12 | 2002-07-18 | Merck & Co Inc | Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
IL157638A0 (en) * | 2001-03-01 | 2004-03-28 | Shionogi & Co | Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
PT2266958T (pt) | 2001-08-10 | 2017-05-10 | Shionogi & Co | Agente antiviral |
EP1441734B1 (en) | 2001-10-26 | 2007-02-28 | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. | Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
US7169780B2 (en) | 2001-10-26 | 2007-01-30 | Istitute Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
AU2003216049B2 (en) | 2002-01-17 | 2008-07-17 | Merck Sharp & Dohme Corp. | Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors |
WO2003077850A2 (en) * | 2002-03-15 | 2003-09-25 | Merck & Co., Inc. | N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
US7109186B2 (en) | 2002-07-09 | 2006-09-19 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
AU2003249531A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Azaisoquinoline derivatives as matrix metalloproteinase inhibitors |
JP2006232849A (ja) * | 2003-08-13 | 2006-09-07 | Japan Tobacco Inc | 含窒素縮合環化合物及びそのhivインテグラーゼ阻害剤としての利用 |
TW200510425A (en) * | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
CA2557926A1 (en) | 2004-03-09 | 2005-09-22 | Monica Donghi | Hiv integrase inhibitors |
WO2005086700A2 (en) | 2004-03-09 | 2005-09-22 | Merck & Co., Inc. | Hiv integrase inhibitors |
CN1929737A (zh) | 2004-03-09 | 2007-03-14 | 默克公司 | Hiv整合酶抑制剂 |
US7741315B2 (en) | 2005-05-10 | 2010-06-22 | Merck Sharp & Dohme Corp. | HIV integrase inhibitors |
-
2005
- 2005-03-09 NZ NZ549449A patent/NZ549449A/en unknown
- 2005-03-09 WO PCT/US2005/007730 patent/WO2005087767A1/en active Application Filing
- 2005-03-09 CN CN2005800074042A patent/CN1930160B/zh not_active Expired - Fee Related
- 2005-03-09 EA EA200601654A patent/EA200601654A1/ru unknown
- 2005-03-09 KR KR1020067018481A patent/KR20070026414A/ko not_active Application Discontinuation
- 2005-03-09 AU AU2005222391A patent/AU2005222391B2/en not_active Ceased
- 2005-03-09 US US10/587,682 patent/US7598264B2/en not_active Expired - Fee Related
- 2005-03-09 JP JP2007502960A patent/JP4625838B2/ja not_active Expired - Fee Related
- 2005-03-09 EP EP05725120A patent/EP1725556A1/en not_active Ceased
- 2005-03-09 WO PCT/US2005/007772 patent/WO2005087768A1/en not_active Application Discontinuation
- 2005-03-09 CA CA2558026A patent/CA2558026C/en not_active Expired - Fee Related
-
2006
- 2006-08-24 CR CR8569A patent/CR8569A/es unknown
- 2006-09-03 IL IL177858A patent/IL177858A0/en unknown
- 2006-09-06 EC EC2006006826A patent/ECSP066826A/es unknown
- 2006-10-05 MA MA29370A patent/MA28519B1/fr unknown
- 2006-10-06 NO NO20064555A patent/NO20064555L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2558026C (en) | 2010-12-14 |
EA200601654A1 (ru) | 2007-02-27 |
ECSP066826A (es) | 2006-11-24 |
AU2005222391B2 (en) | 2010-11-11 |
JP2007528401A (ja) | 2007-10-11 |
CN1930160B (zh) | 2011-11-16 |
US7598264B2 (en) | 2009-10-06 |
JP4625838B2 (ja) | 2011-02-02 |
CA2558026A1 (en) | 2005-09-22 |
WO2005087767A1 (en) | 2005-09-22 |
WO2005087768A1 (en) | 2005-09-22 |
IL177858A0 (en) | 2006-12-31 |
CN1930160A (zh) | 2007-03-14 |
NZ549449A (en) | 2009-05-31 |
KR20070026414A (ko) | 2007-03-08 |
US20070179196A1 (en) | 2007-08-02 |
AU2005222391A1 (en) | 2005-09-22 |
MA28519B1 (fr) | 2007-04-03 |
NO20064555L (no) | 2006-12-04 |
EP1725556A1 (en) | 2006-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR8569A (es) | Inhibidores de integrasa de vih | |
ECSP099373A (es) | Inhibidores de transcriptasa inversa no nucleosídicos | |
CR9694A (es) | Inhibidores de la transcriptasa reversa de vih | |
MX2019007262A (es) | Compuestos antivirales de bencilamina fosfodiamida. | |
GT201500088A (es) | Derivados de 5-fenoxi-3h-pirimidin-4-ona y su uso como inhibidores de la transcriptasa inversa del vih | |
CL2008003406A1 (es) | Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih. | |
ECSP12012201A (es) | Inhibidores no nucleosídicos de la transcriptasa inversa | |
CO6382127A2 (es) | Inhibidores de la integrasa del vih | |
MX2008008556A (es) | Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias. | |
AR077125A1 (es) | Combinaciones farmaceuticas utiles para tratar el vhc | |
AR077138A1 (es) | Composiciones farmaceuticas utiles para tratar el vhc | |
CO6531485A2 (es) | Composiciones farmacéuticas sólidas que contienen un inhibidor de la integrasa | |
CR20230100A (es) | Compuestos fosfolípidos y usos de los mismos | |
ATE517899T1 (de) | Hiv-integrasehemmer | |
DOP2006000176A (es) | Inhibidores de la transcriptasa reversa de vih | |
DOP2005000105A (es) | Inhibidores de la integrasa del vih | |
UY31541A1 (es) | 1(2)h-tetrazol-5-il-fenil-oxazolidinona s como agentes antibacterianos | |
ECSP088126A (es) | Inhibidores de la transcriptasa reversa de vih | |
CL2022000225A1 (es) | Forma polimórfica estable de 6-fluoro-9-metil-9h-ß-carbolina y usos de la misma | |
TNSN06270A1 (en) | Hiv integrase inhibitors | |
TW200640460A (en) | HIV integrase inhibitors | |
CR7509A (es) | Heterotriciclil-6-alquiliden-penems como inhibidores de beta-lactamasa | |
TN2011000151A1 (en) | Hiv integrase inhibitors | |
DOP2001000263A (es) | Aza y poliaza-naftalenil carboxamidas utiles como inhibidores de la integrasa de vih | |
UA108495C2 (en) | Reverse transcriptase nucleoside inhibitors |